• 1. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 2. Excellent energy storage performance in NaNbO3-based relaxor antiferroeic ceramics under a low electric field
  XuxinCheng,XiaomingChen,PengyuanFan
• 3. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 4. Embedding cyclic nitrone in mesoporous silica particles for EPR spin trapping of superoxide and other radicals?
  Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
• 5. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Aldehyde/Ketone

Introduction to 1-(2-bromo-4-fluorophenyl)ethan-1-one (CAS No. 1006-39-9)

1-(2-bromo-4-fluorophenyl)ethan-1-one, with the chemical formula C₈H₆BrFO, is a fluorinated aromatic ketone that has garnered significant attention in the field of pharmaceutical chemistry and organic synthesis. This compound, identified by its CAS number 1006-39-9, serves as a versatile intermediate in the development of various bioactive molecules. Its unique structural features, including the presence of both bromine and fluorine substituents on the aromatic ring, make it a valuable building block for designing novel therapeutic agents.

The significance of 1-(2-bromo-4-fluorophenyl)ethan-1-one lies in its ability to undergo a wide range of chemical transformations, which are highly conducive to medicinal chemistry applications. The bromine atom at the 2-position and the fluorine atom at the 4-position introduce electrophilic and electron-withdrawing effects, respectively, influencing the reactivity and electronic properties of the molecule. These characteristics have been exploited in synthetic strategies to develop compounds with enhanced binding affinity and selectivity towards biological targets.

In recent years, there has been a surge in research focused on fluorinated aromatic compounds due to their improved metabolic stability, lipophilicity, and binding properties compared to their non-fluorinated counterparts. 1-(2-bromo-4-fluorophenyl)ethan-1-one has been particularly studied for its role in synthesizing small-molecule inhibitors targeting enzymes involved in cancer metabolism. For instance, studies have demonstrated its utility in generating kinase inhibitors that exhibit potent activity against tyrosine kinases, which are crucial in signal transduction pathways associated with tumor growth and progression.

The incorporation of fluorine into drug candidates has been shown to modulate pharmacokinetic profiles, leading to increased bioavailability and reduced susceptibility to degradation by metabolic enzymes. The bromine substituent further enhances the reactivity of 1-(2-bromo-4-fluorophenyl)ethan-1-one, allowing for facile functionalization via cross-coupling reactions such as Suzuki-Miyaura and Buchwald-Hartwig couplings. These reactions are pivotal in constructing complex molecular architectures essential for drug discovery efforts.

One notable application of 1-(2-bromo-4-fluorophenyl)ethan-1-one is in the synthesis of antiviral agents. Researchers have leveraged its structural framework to develop compounds that interfere with viral replication mechanisms. The fluorine atom's ability to participate in hydrogen bonding interactions has been particularly advantageous in designing molecules that bind tightly to viral proteases and polymerases. This has opened up new avenues for developing treatments against RNA viruses, including those responsible for emerging infectious diseases.

The compound's role in medicinal chemistry extends beyond antiviral applications. It has also been utilized in the development of anti-inflammatory agents, where its structural motifs contribute to inhibiting inflammatory cytokine production. By targeting key enzymes such as cyclooxygenase (COX) and lipoxygenase (LOX), derivatives of 1-(2-bromo-4-fluorophenyl)ethan-1-one have shown promise in reducing inflammation without the side effects associated with traditional nonsteroidal anti-inflammatory drugs (NSAIDs).

Advances in computational chemistry have further enhanced the utility of 1-(2-bromo-4-fluorophenyl)ethan-1-one as a scaffold for drug design. Molecular modeling studies indicate that modifications at the 2-bromo and 4-fluoro positions can fine-tune physicochemical properties such as solubility, permeability, and binding affinity. These insights have guided synthetic chemists in optimizing lead compounds towards clinical candidates.

The synthesis of 1-(2-bromo-4-fluorophenyl)ethan-1-one itself is an elegant example of modern organic synthesis techniques. Traditional methods involve bromination followed by fluorination of an appropriate precursor, often employing palladium-catalyzed cross-coupling reactions for high selectivity. Recent innovations have focused on greener synthetic routes, utilizing photoredox catalysis or electrochemical methods to achieve regioselective transformations without harsh reagents.

In conclusion, 1-(2-bromo-4-fluorophenyl)ethan-1-one (CAS No. 1006-39-9) represents a cornerstone compound in pharmaceutical research due to its versatility and functional group compatibility. Its contributions to drug discovery span multiple therapeutic areas, from oncology to infectious diseases, underscoring its importance as a synthetic intermediate. As research continues to uncover new applications for fluorinated aromatic compounds, 1-(2-bromo-4-fluorophenyl)ethan-1-one will undoubtedly remain at the forefront of medicinal chemistry innovation.

• 594810-90-9(2-bromo-1-(2-bromo-4-fluorophenyl)ethanone)
• 13294-43-4(Benzophenone,2-bromo-5-fluoro- (7CI,8CI))
• 127371-55-5(1-(2-Bromo-4,5-difluorophenyl)ethanone)
• 928715-37-1(1-(2-bromo-6-fluorophenyl)ethan-1-one)
• 573-46-6(2-Bromo-4'-Fluorobenzophenone)
• 1006-33-3(2'-Bromo-5'-fluoroacetophenone)
• 1514581-21-5(1-(2-bromo-6-fluoro-3-methylphenyl)ethan-1-one)
• 36282-27-6(Ethanone, 1-(2-bromo-4-fluorophenyl)-2-phenyl-)
• 59142-70-0(Methanone, (2-bromo-4-fluorophenyl)(4-fluorophenyl)-)
• 161957-58-0(1-(2-Bromo-3-fluorophenyl)ethanone)